Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Between over- and undertreatment of invasive fungal disease.

Literature DB >> 16206098

Between over- and undertreatment of invasive fungal disease.

Ben E de Pauw.

Abstract

Entities: Disease

Mesh：

Substances：
Antifungal Agents

Year: 2005 PMID： 16206098 DOI： 10.1086/496933

Source DB: PubMed Journal: Clin Infect Dis ISSN： 1058-4838 Impact factor: 9.079

Keyword Cloud
Cited

× No keyword cloud information.

15 in total

Review 1. Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection.

Authors: Jean Klastersky; Marianne Paesmans
Journal: Support Care Cancer Date: 2006-09-12 Impact factor: 3.603

2. Early diagnosis and preemptive therapy of pulmonary mold infections in high-risk patients.

Authors: Johan Maertens; Griet Huysmans; Koen Theunissen
Journal: Curr Infect Dis Rep Date: 2008-11 Impact factor: 3.725

Review 3. Treatment principles for the management of mold infections.

Authors: Dimitrios P Kontoyiannis; Russell E Lewis
Journal: Cold Spring Harb Perspect Med Date: 2014-11-06 Impact factor: 6.915

4. Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study.

Authors: G Maschmeyer; W J Heinz; B Hertenstein; H-A Horst; C Requadt; T Wagner; O A Cornely; J Löffler; M Ruhnke
Journal: Eur J Clin Microbiol Infect Dis Date: 2012-12-28 Impact factor: 3.267

Review 5. Recent developments in the management of invasive fungal infections in patients with oncohematological diseases.

Authors: Markus Ruhnke; Stefan Schwartz
Journal: Ther Adv Hematol Date: 2016-07-01

6. Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?

Authors: Rafael Zaragoza; Javier Pemán; Miguel Salavert; Angel Viudes; Amparo Solé; Isidro Jarque; Emilio Monte; Eva Romá; Emilia Cantón
Journal: Ther Clin Risk Manag Date: 2008-12 Impact factor: 2.423

Between over- and undertreatment of invasive fungal disease.

Review 1. Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection.

2. Early diagnosis and preemptive therapy of pulmonary mold infections in high-risk patients.

Review 3. Treatment principles for the management of mold infections.

4. Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study.

Review 5. Recent developments in the management of invasive fungal infections in patients with oncohematological diseases.

6. Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?

Review 7. Diagnostic methods for invasive fungal diseases in patients with hematologic malignancies.

Review 8. Antifungal management in cancer patients.

9. Adherence to, and outcomes of, a galactomannan screening protocol in high-risk hematology patients.

10. A risk prediction score for invasive mold disease in patients with hematological malignancies.